Growth Metrics

Nova (NVMI) EBITDA (2016 - 2025)

Historic EBITDA for Nova (NVMI) over the last 17 years, with Q3 2025 value amounting to $63.9 million.

  • Nova's EBITDA rose 2971.5% to $63.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $248.2 million, marking a year-over-year increase of 4976.44%. This contributed to the annual value of $187.5 million for FY2024, which is 4179.32% up from last year.
  • Per Nova's latest filing, its EBITDA stood at $63.9 million for Q3 2025, which was up 2971.5% from $65.6 million recorded in Q2 2025.
  • Nova's EBITDA's 5-year high stood at $65.6 million during Q2 2025, with a 5-year trough of $19.8 million in Q1 2021.
  • Its 5-year average for EBITDA is $40.8 million, with a median of $37.0 million in 2022.
  • As far as peak fluctuations go, Nova's EBITDA soared by 16378.09% in 2021, and later tumbled by 2231.15% in 2023.
  • Nova's EBITDA (Quarter) stood at $29.9 million in 2021, then grew by 23.52% to $36.9 million in 2022, then fell by 8.83% to $33.7 million in 2023, then surged by 64.79% to $55.5 million in 2024, then rose by 15.12% to $63.9 million in 2025.
  • Its EBITDA stands at $63.9 million for Q3 2025, versus $65.6 million for Q2 2025 and $63.2 million for Q1 2025.